Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis)

Journal of the American College of Cardiology

Volumn 63, Issue 12, 2014, Pages 1214-1222

  Van Ballegooijen, Adriana J ^a   Kestenbaum, Bryan ^b   Sachs, Michael C ^b   De Boer, Ian H ^b   Siscovick, David S ^b   Hoofnagle, Andrew N ^c   Ix, Joachim H ^d   Visser, Marjolein ^a   Brouwer, Ingeborg A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

incident hypertension; parathyroid hormone; prospective study; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOASSAY; INCIDENCE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; VITAMIN BLOOD LEVEL;

INCIDENT HYPERTENSION; PARATHYROID HORMONE; PROSPECTIVE STUDY; VITAMIN D;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; UNITED STATES; VITAMIN D;

EID: 84896908549     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.012     Document Type: Article

References (34)

1. C.M. Lawes, S. Vander Hoorn, and A. Rodgers Global burden of blood-pressure-related disease, 2001 Lancet 371 2008 1513 1518
2. R. Jorde, J. Svartberg, and J. Sundsfjord Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men J Hypertens 23 2005 1639 1644
3. E.N. Taylor, G.C. Curhan, and J.P. Forman Parathyroid hormone and the risk of incident hypertension J Hypertens 26 2008 1390 1394
4. J.L. Anderson, R.C. Vanwoerkom, and B.D. Horne et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors? Am Heart J 162 2011 331 339
5. A. Tomaschitz, E. Ritz, and B. Pieske et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease Cardiovasc Res 94 2012 10 19
6. J.P. Forman, G.C. Curhan, and E.N. Taylor Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women Hypertension 52 2008 828 832
7. J.P. Forman, E. Giovannucci, and M.D. Holmes et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension Hypertension 49 2007 1063 1069
8. I. Al Mheid, R. Patel, and J. Murrow et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans J Am Coll Cardiol 58 2011 186 192
9. K.L. Margolis, L.W. Martin, and R.M. Ray et al. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women Am J Epidemiol 175 2012 22 32
10. L. Ke, B.I. Graubard, and D. Albanes et al. Hypertension, pulse, and other cardiovascular risk factors and vitamin D status in finnish men Am J Hypertens 26 2013 951 956
11. D.E. Bild, D.A. Bluemke, and G.L. Burke et al. Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
12. C. Bosworth, M.C. Sachs, and D. Duprez et al. Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis Clin Endocrinol 79 2013 429 436
13. M.C. Sachs, A. Shoben, and G.P. Levin et al. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis Am J Clin Nutr 97 2013 1243 1251
14. R. Eastell, A. Arnold, and M.L. Brandi et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop J Clin Endocrinol Metab 94 2009 340 350
15. N.R. Bartlett A survival model for a wood preservative trial Biometrics 34 1978 673 679
16. B. Kestenbaum, R. Katz, and I. de Boer et al. Vitamin d, parathyroid hormone, and cardiovascular events among older adults J Am Coll Cardiol 58 2011 1433 1441
17. R. Jorde, Y. Figenschau, N. Emaus, M. Hutchinson, and G. Grimnes Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension Hypertension 55 2010 792 798
18. M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, and C. Hansen Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women J Clin Endocrinol Metab 86 2001 1633 1637
19. J.P. Forman, J.B. Scott, and K. Ng et al. Effect of vitamin D supplementation on blood pressure in blacks Hypertension 61 2013 779 785
20. A.D. Gepner, R. Ramamurthy, D.C. Krueger, C.E. Korcarz, N. Binkley, and J.H. Stein A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk PLoS One 7 2012 e36617
21. K.L. Margolis, R.M. Ray, and L. Van Horn et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial Hypertension 52 2008 847 855
22. M.D. Witham, R.J. Price, and A.D. Struthers et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: The VitDISH Randomized Controlled Trial JAMA Intern Med 173 2013 1672 1679
23. M. Suzuki, M. Yoshioka, and M. Hashimoto et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease Am J Clin Nutr 97 2013 1004 1013
24. G.P. Levin, C. Robinson-Cohen, and I.H. de Boer et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes JAMA 308 2012 1898 1905
25. S. Chen, C.S. Law, and C.L. Grigsby et al. Cardiomyocyte-specific deletion of the vitamin d receptor gene results in cardiac hypertrophy Circulation 124 2011 1838 1847
26. E. Osto, F. Fallo, and M.R. Pelizzo et al. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy Circulation 126 2012 1031 1039
27. A. Tomaschitz, S. Pilz, and E. Ritz et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study Clin Chim Acta 411 2010 1354 1360
28. L. Morfis, P. Smerdely, and L.G. Howes Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures J Hypertens 15 1997 1271 1276
29. R. Jorde, J. Sundsfjord, E. Haug, and K.H. Bonaa Relation between low calcium intake, parathyroid hormone, and blood pressure Hypertension 35 2000 1154 1159
30. A.J. van Ballegooijen, I. Reinders, M. Visser, and I.A. Brouwer Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies Am Heart J 165 2013 655 664
31. Y. Dong, I.S. Stallmann-Jorgensen, and N.K. Pollock et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness J Clin Endocrinol Metab 95 2010 4584 4591
32. J.C. Gallagher, A. Sai, T. Templin 2nd, and L. Smith Dose response to vitamin D supplementation in postmenopausal women: a randomized trial Ann Intern Med 156 2012 425 437
33. C.P. Earthman, L.M. Beckman, K. Masodkar, and S.D. Sibley The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications Int J Obes (Lond) 36 2012 387 396
34. E. Grethen, K.M. Hill, and R. Jones et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity J Clin Endocrinol Metab 97 2012 1655 1662